Cerenome, Inc.
CNSY
NASDAQ·Healthcare·Medical - Pharmaceuticals·Mkt cap $19.0M
$2.76
▼ -7.55%
P/E
-1.17
Mkt Cap
$19.0M
52-Wk Range
$2.62–$23.50
52-Week Range
$2.62 - $23.50
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 32.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Average volatility.
Growth
Strong growth ahead
Value
Valuation data unavailable
Momentum
Falling
-32.0% over 3m
Quality
Excellent
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying CNSY right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
AUG 14, 2026
Reported EPS of -$1.31 vs -$0.88 consensus (-48.9% surprise). Revenue of $411.0K vs $1.1M expected (-63.1%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-48.9%
Revenue trend · last 2Q
—
-70%
Q1 26
Q2 26
$1.0M
$411.0K
Margins · last 2Q
Profit
-2191.2%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How CNSY stacks vs Medical - Pharmaceuticals
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.